Evaluation of a clinical pharmacist-led antimicrobial stewardship program in a neurosurgical intensive care unit: a pre-and post-intervention cohort study

被引:0
|
作者
Yu, Jing [1 ,2 ]
Liu, Yan [1 ,2 ]
Qu, Ruochen [1 ,2 ]
Wang, Ziyang [3 ]
Zhao, Yan [1 ,2 ]
Zhao, Yuanyuan [1 ,2 ]
Zhou, Chunhua [1 ,2 ]
机构
[1] Hebei Med Univ, Hosp 1, Dept Clin Pharm, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Hosp 1, Technol Innovat Ctr Artificial Intelligence Clin P, Shijiazhuang, Peoples R China
[3] Hebei Med Univ, Dept Clin Pharm, Shijiazhuang, Peoples R China
关键词
microbial; mortality; antimicrobial stewardship; neurosurgical intensive care units; drug resistance; CRITICALLY-ILL PATIENTS; MULTICENTER; MENINGITIS; GUIDELINES; MANAGEMENT;
D O I
10.3389/fphar.2023.1263618
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Antimicrobial resistance poses a significant challenge in neurosurgical intensive care units (ICU). The excessive use of broad-spectrum antibiotics is closely linked to the emergence and dissemination of drug-resistant bacteria within neurosurgical ICUs. This study assessed the effects of implementing a comprehensive Antimicrobial Stewardship (AMS) program in a neurosurgical ICU setting.Methods: From April 2022 to September 2022, an AMS program was implemented in the neurosurgical ICU. The program involved the regular presence of a pharmacist and an infectious disease physician who conducted prospective audits and provided feedback. To assess the impact of the AMS program, the outcome measures were compared between the AMS period and the 6 months before AMS implementation (pre-AMS period). The primary outcome was the use of antibacterial agents, including anti-pseudomonal beta-lactams (APBLs), polymyxin, and tigecycline. Additionally, the study evaluated the appropriateness of antimicrobial de-escalation and the susceptibility of Gram-negative bacilli to antimicrobial agents.Results: A total of 526 were included during the AMS period, while 487 patients were included in the pre-AMS period. The two groups had no significant differences in disease severity and mortality rates. During the AMS period, there was a notable decrease in the use of APBLs as empiric treatment (43.92% vs. 60.99%, p < 0.001). Multi-drug resistant organism (MDRO) infections decrease significantly during AMS period (11.03% vs. 18.48%, p < 0.001). The number of prescription adjustment increased significantly in all patients (0 item vs. 0 item, p < 0.001) and MDRO-positive patients (3 items vs. 2 items, p < 0.001) during the AMS period. Additionally, appropriate antimicrobial de-escalation for patients with MDRO showed improvement during the AMS period (39.66% vs. 20%, p = 0.001). Polymyxin utilization also decreased during the AMS period (15.52% vs. 31.11%, p = 0.034). Furthermore, the susceptibility of Gram-negative Bacilli isolates to APBLs was significantly higher during the AMS period.Conclusion: Implementing a comprehensive pharmacist-led AMS program led to a decrease in the use of antibacterial agents. This reduction in usage is significant because it can potentially delay the emergence of bacterial resistance.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Evaluation of a Clinical Pharmacist Dosage-Adjustment Intervention in a Teaching Hospital Medical Intensive Care Unit
    Park, So Jin
    Suh, Gee Young
    Lee, Young Mi
    Lee, Yu Jeung
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (04): : 579 - 586
  • [42] Evaluation of PHARM-HF, a pharmacist-led heart failure medication titration clinic: A pre-post study
    Ladhar, Simroop
    Hawkins, Nathaniel M.
    Virani, Sean A.
    Turgeon, Ricky D.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2024, 7 (05): : 416 - 425
  • [43] An Effectiveness Study of a Primary Care-embedded Clinical Pharmacist-Led Intervention Among Patients With Diabetes and Medicaid Coverage
    Narain, Kimberly Danae Cauley
    Tseng, Chi-Hong
    Bell, Douglas
    Do, Amanda
    Follett, Rob
    Duru, O. Kenrik
    Moreno, Gerardo
    Mangione, Carol
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (01) : 66 - 73
  • [44] Clinical and economic effects of an antimicrobial stewardship intervention in a surgical intensive care unit (vol 85, pg 613, 2020)
    Stocker, Hartmut
    Mehlhorn, Cornelia
    Jordan, Kati
    Eckholt, Leila
    Jefferys, Laura
    Arasteh, Keikawus
    INFECTION, 2020, 48 (04) : 521 - 521
  • [45] Antimicrobial stewardship program in a pediatric intensive care unit of a tertiary care children’s hospital in Saudi Arabia – a pilot study
    LS AlAwdah
    D AlShahrani
    M AlShehri
    T AlFawaz
    N ElSidig
    A AlAwfi
    K Baba
    A AlAqeel
    A AlSharif
    I AlHarfi
    S Amjad
    A AlDarwish
    S Rasheed
    Antimicrobial Resistance and Infection Control, 4 (Suppl 1)
  • [46] Evaluation of a Multidisciplinary Antimicrobial Stewardship Program in a Saudi Critical Care Unit: A Quasi-Experimental Study
    Haseeb, Abdul
    Faidah, Hani Saleh
    Al-Gethamy, Manal
    Iqbal, Muhammad Shahid
    Barnawi, Abrar Mohammed
    Elahe, Shuruq S.
    Bukhari, Duha Nabeel
    Al-Sulaimani, Turki Mohammad Noor
    Fadaaq, Mohammad
    Alghamdi, Saad
    Almalki, Waleed Hassan
    Saleem, Zikria
    Elrggal, Mahmoud Essam
    Khan, Amer Hayat
    Algarni, Mohammed A.
    Ashgar, Sami S.
    Hassali, Mohamed Azmi
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [47] Evaluation of a pharmacist-led intervention to reduce drug-related problems in patients included in a home healthcare program: study protocol for a pragmatic randomized clinical trial
    Clara Salom-Garrigues
    Enric Aragonès
    Montse Giralt
    Cecília Campabadal Prats
    Ferran Bejarano-Romero
    Laura Canadell
    BMC Geriatrics, 24
  • [48] Development of a national neonatal intensive care unit-specific antimicrobial stewardship programme in Canada: protocol for a cohort study
    Ting, Joseph Y.
    Roberts, Ashley
    Tilley, Peter
    Robinson, Joan L.
    Dunn, Michael S.
    Paquette, Vanessa
    Lee, Kyong-Soon
    Shah, Vibhuti
    Yoon, Eugene
    Richter, Lindsay L.
    Lodha, Abhay
    Shivananda, Sandesh
    Thampi, Nisha
    Autmizguine, Julie
    Shah, Prakesh S.
    BMJ OPEN, 2020, 10 (12):
  • [49] Impact of a Multimodal Analgesia Protocol in an Intensive Care Unit: A Pre-post Cohort Study
    de Souza, Renato Lucas P.
    Abrao, Joao
    Garcia, Luis, V
    Moutinho, Sofia Vila
    Wiggers, Ester
    Balestra, Andiamira Cagnoni
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [50] Impact of a clinical pharmacist-led stewardship program for the appropriate use of acid suppression therapy in older hospitalized patients: a non-randomized controlled study
    Dumlu, Hatice Ikra
    Sancar, Mesut
    Ozdemir, Ali
    Okuyan, Betul
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (04) : 914 - 921